Breaking News Instant updates and real-time market news.

PPG

PPG

$129.82

-0.5 (-0.38%)

, PG

Procter & Gamble

$120.49

-0.15 (-0.12%)

17:49
11/14/19
11/14
17:49
11/14/19
17:49

Trian Fund exits PPG, cuts Wendy's in Q3

Nelson Peltz' Trian Fund disclosed in an SEC filing its holdings as of September 30, 2019. Trian had no new buys in the third quarter. The firm exited one position during the quarter, which was PPG Industries (PPG). Trian increased its stake in four holdings, including by size of previous position Procter & Gamble (PG), Mondelez (MDLZ), Legg Mason (LM), and General Electric (GE). The firm reduced its stake in two holdings, including by size of previous position Wendy's (WEN) and Bank of New York Mellon (BK). Trian Fund's top holdings as of September 30, in order of size, were P&G, Sysco (SYY), Mondelez, General Electric, and Bank of New York Mellon.

PPG

PPG

$129.82

-0.5 (-0.38%)

PG

Procter & Gamble

$120.49

-0.15 (-0.12%)

MDLZ

Mondelez

$52.90

0.2 (0.38%)

LM

Legg Mason

$38.60

-0.22 (-0.57%)

GE

General Electric

$11.30

-0.01 (-0.09%)

WEN

Wendy's

$20.90

-0.01 (-0.05%)

BK

BNY Mellon

$48.42

0.07 (0.14%)

SYY

Sysco

$81.51

0.27 (0.33%)

  • 14

    Nov

  • 15

    Nov

  • 19

    Nov

  • 19

    Nov

  • 02

    Dec

  • 11

    Dec

  • 16

    Jan

  • 29

    Jan

PPG PPG
$129.82

-0.5 (-0.38%)

10/25/19
JPMS
10/25/19
UPGRADE
Target $33
JPMS
Overweight
JPMorgan upgrades Axalta to Overweight on discount to PPG
JPMorgan analyst Jeffrey Zekauskas upgraded Axalta Coating Systems (AXTA) to Overweight from Neutral with a price target of $33, up from $31. Axalta is the North American coatings company with the lowest valuation, Zekauskas tells investors in a research note. The company is trading at a three-times multiple point discount to PPG Industries (PPG), its closest comparable, while it historically has traded at a one-to-times multiple point discount, says the analyst. In addition, Axalta has publicly stated that it is exploring strategic options, says Zekauskas, who sees a 25% probability of a bid for the company over the intermediate term.
11/01/19
MSCO
11/01/19
INITIATION
Target $130
MSCO
Equal Weight
PPG resumed with an Equal Weight at Morgan Stanley
Morgan Stanley analyst Vincent Andrews resumed coverage of PPG Industries with an Equal Weight rating and $130 price target. With PPG's valuation at the high end of its historical range, the stock's risk/reward is balanced at current levels, Andrews tells investors in a research note.
11/01/19
11/01/19
INITIATION

Fly Intel: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Digi International (DGII) initiated with an Outperform at Baird. 2. Wave Life Sciences (WVE) initiated with a Buy at Guggenheim. 3. PPG (PPG) resumed with an Equal Weight at Morgan Stanley. 4. Homology Medicines (FIXX) initiated with a Perform at Oppenheimer. 5. Sarepta (SRPT) initiated with a Buy at Guggenheim. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
11/06/19
BREN
11/06/19
INITIATION
Target $150
BREN
Buy
PPG initiated with a Buy at Berenberg
Berenberg analyst Anthony Manning initiated coverage of PPG Industries with a Buy rating and $150 price target. The analyst believes the paints and coatings industry remains attractive and expects its margin expansion to outpace the wider chemicals industry. PPG is his preferred pick in the sector.
PG Procter & Gamble
$120.49

-0.15 (-0.12%)

09/27/19
NORL
09/27/19
NO CHANGE
NORL
Outperform
Digimarc solution being tested by P&G, other CPG companies, says Northland
Northland analyst Gus Richard said that Procter & Gamble (PG) has tested Digimarc Barcode for inspection of product labeling and he believes a few CPG companies are working with Digimarc's (DMRC) technology for manufacturing applications. He estimates P&G could generate over $100,000 for Digimarc, assuming a low rate of adoption by P&G in manufacturing next year, Richard tells investors. He keeps an Outperform rating on Digimarc shares.
10/23/19
MSCO
10/23/19
NO CHANGE
Target $125
MSCO
Overweight
Procter & Gamble results could bode well for Walmart, says Morgan Stanley
Morgan Stanley analyst Simeon Gutman noted that three of the four companies with the greatest weight in the Consumer Staples Sector SPDR (XLP) - PepsiCo (PEP), Coca-Cola (KO) and now Procter & Gamble (PG) - have reported solid Q3 results. He thinks the group's momentum could have a positive read-through to Walmart (WMT), which will report its fiscal Q3 results on November 14. Gutman added that the correlation between Walmart's total comps and P&G volume growth on a trailing five year basis has improved in the past couple of quarters and both companies' revenue trajectories have trended in a similar direction since "around 2015." Gutman keeps an Overweight rating on Walmart shares with a $125 price target.
10/23/19
MACQ
10/23/19
NO CHANGE
Target $138
MACQ
Outperform
Procter & Gamble price target raised to $138 from $132 at Macquarie
Macquarie analyst Caroline Levy raised her price target for Procter & Gamble to $138 from $132 and reiterates an Outperform rating on the shares citing the company's "very strong" fiscal Q1 results. Sales growth was better than expected across all divisions and in key geographies including the U.S. and China, Levy tells investors in a research note titled "Powerful & Gaining." She points out that Procter gained market share in eight of its 10 categories in its largest market, the U.S. This is a "dramatic improvement" from just a few years ago when share losses felt irreversible, Levy contends.
10/25/19
MSCO
10/25/19
NO CHANGE
Target $134
MSCO
Overweight
Procter & Gamble shares still compelling despite 50% run-up, says Morgan Stanley
Morgan Stanley analyst Dara Mohsenian reiterates an Overweight rating on Procter & Gamble, stating that he still expects outperformance despite the stock's 50% run-up over the last year as he sees further potential EPS upside on higher than expected organic sales growth and an above-consensus gross margin inflection. A few key details from its Q1 report - such as accelerating 2-year average organic sales growth, volume outperformance and reduced pricing risk - give him further confidence, said Mohsenian, who has a $134 price target on P&G shares.
MDLZ Mondelez
$52.90

0.2 (0.38%)

10/16/19
RBCM
10/16/19
INITIATION
Target $66
RBCM
Outperform
Mondelez initiated with an Outperform at RBC Capital
RBC Capital started Mondelez International with an Outperform rating and $66 price target.
08/07/19
MSCO
08/07/19
UPGRADE
MSCO
Overweight
Mondelez upgraded to Overweight from Equal Weight at Morgan Stanley
08/07/19
08/07/19
UPGRADE
Target $62

Overweight
Mondelez upgraded to Overweight at Morgan Stanley on topline growth view
As previously reported, Morgan Stanley analyst Dara Mohsenian upgraded Mondelez to Overweight with an unchanged price target of $62. The analyst cites increased confidence in the company's expected sales growth and sees the management's "positive strategy changes" already working, saying the stock should re-rate closer to multinational CPG peers than US-centric food peers.
10/17/19
10/17/19
INITIATION
Target $66

Outperform
Mondelez initiated with an Outperform at RBC Capital
As previously reported, RBC Capital analyst Nik Modi initiated coverage of Mondelez with an Outperform rating and $66 price target. The analyst notes that the "material operating changes" and upgrades in capabilities made by the company's management over the past year will position it to deliver revenue growth rates that are near the upper end of the large-cap Consumer Staples sector range. Modi also contends that the long-term 3% revenue growth and high-single-digit earnings targets of Mondelez are "achievable with upside potential".
LM Legg Mason
$38.60

-0.22 (-0.57%)

07/09/19
MSCO
07/09/19
NO CHANGE
MSCO
Morgan Stanley sees C-corp conversion announcement coming from Carlyle
Morgan Stanley analyst Michael Cyprys said he recommends owning Carlyle Group (CG) shares into the quarter, as he believes the company will announce plans to convert to a C-corporation along with its upcoming report, "albeit with a delayed effective date" to allow time for the complex underlying tax impact analysis. He thinks a conversion could bring greater clarity and visibility into targets, which could increase long only interest in the stock, Cyprys tells investors. In his broader preview of the earnings season for the Asset Manager group, the analyst noted that he lowered his Q2 EPS estimates by about 4% on average, cutting his estimates for Traditionals by 0.5%, for Alts by 11.5% and for Market Structure companies by 1.6%.
10/03/19
KBWI
10/03/19
DOWNGRADE
Target $19.5
KBWI
Underperform
Janus Henderson downgraded to Underperform from Market Perform at Keefe Bruyette
Keefe Bruyette anlayst Robert Lee downgraded Janus Henderson Group to Underperform from Market Perform with a price target of $19.50, down from $21. The analyst sees a "challenged" organic growth outlook heading into a "seasonally weak" Q4. Amid poor investor sentiment and concerns over the direction of operating trends, he sees a re-valuation higher of stocks in the asset manager space as "highly problematic." Legg Mason (LM) and Legg Mason (BLK) are Lee's top picks into the Q3 earnings season.
09/13/19
09/13/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. O'Reilly Automotive (ORLY) downgraded to Neutral from Buy at Citi with analyst Gregory Badishkanian stating he views O'Reilly as a "best-in-class operator" but is on the sidelines due to valuation. 2. Legg Mason (LM) downgraded to Market Perform from Outperform at Wells Fargo with analyst Christopher Harris saying he believes "substantial value" in Legg Mason has now been unlocked following the implementation of an aggressive cost savings plan and the stock's "meaningful" outperformance year-to-date. 3. Cboe Global Markets (CBOE) downgraded to Underperform from Buy at BofA/Merrill with analyst Michael Carrier noting trends have moderated some in September while its compares in Q4 are tough. 4. Huntington Bancshares (HBAN) downgraded to Neutral from Buy at DA Davidson with analyst Kevin Reevey saying that after a 22.9% rise in its stock price year-to-date and 32% from its 52-week low, the stock is now trading at 9.5% premium to its peers with an earnings multiple of 10.5-times his expected FY20 earnings. 5. Broadcom (AVGO) downgraded to Hold from Buy at Loop Capital with analyst Cody Acree noting that the company met expectations for Q3, but management has warned about the "very low-growth environment" expected for the foreseeable future unless the macro backdrop improves. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
09/13/19
WELS
09/13/19
DOWNGRADE
Target $43
WELS
Market Perform
Legg Mason downgraded to Market Perform from Outperform at Wells Fargo
Wells Fargo analyst Christopher Harris downgraded Legg Mason to Market Perform from Outperform with an unchanged price target of $43. The analyst believes "substantial value" in Legg Mason has now been unlocked following the implementation of an aggressive cost savings plan and the stock's "meaningful" outperformance year-to-date. Further, the analyst anticipates a "challenging backdrop" for revenue growth and as such, views the shares as fairly valued near current levels.
GE General Electric
$11.30

-0.01 (-0.09%)

11/05/19
GABE
11/05/19
NO CHANGE
GABE
Buy
Gabelli recommends buying General Electric shares after Q3 report
Gabelli analyst Justin Bergner recommends buying General Electric shares following the company's Q3 report, which he said featured a "benign" insurance update as well as better than expected free cash flow and EPS guidance. He sees the report further reducing the potential for future negative surprises and "helping close the discount" to his unchanged $17 2020 Private Market Value. Bergner keeps a Buy rating on GE shares.
11/05/19
MSCO
11/05/19
NO CHANGE
Target $11
MSCO
Equal Weight
General Electric tail risk 'appears much smaller' after Q3, says Morgan Stanley
Morgan Stanley analyst Joshua Pokrzywinski said the significant tail risk from Long Term Care and pensions at General Electric "appears much smaller" after the "trimming of the tails" with its third quarter report. Having addressed the tail risk with a positive update on pension and LTC, the question then turns to how quickly can performance accelerate and while he sees the risk/reward "evolving more favorably," he also sees little change to core earnings power or secular growth. Pokrzywinski keeps an Equal Weight rating on GE shares and raised his price target on the stock to $11 from $10.
11/04/19
LEHM
11/04/19
NO CHANGE
Target $12
LEHM
Overweight
Investors may start looking at GE with bull case becoming clearer, says Barclays
General Electric's Q3 contained "no nasty surprises" from legacy liabilities along with "some clear signs of progress amidst the house-cleaning," Barclays analyst Julian Mitchell tells investors in a research note. The analyst believes this will likely cause more long-term investors to start to take a closer look at GE during the second year of CEO Larry Culp's tenure. With GE's free cash flow bull case becoming clearer, long-term investors may start to take a look, says Mitchell. The analyst keeps an Overweight rating on General Electric shares with a $12 price target. The stock closed Friday up 40c to $10.38.
11/13/19
JPMS
11/13/19
NO CHANGE
JPMS
Underweight
JPMorgan's Tusa disagrees with reasons behind GE share rally
Key to the recent bounce in shares of General Electric is the notion that management has set a bottom on fundamentals, with the company "raising" guidance a sign of change in the revision trajectory, JPMorgan analyst Stephen Tusa tells investors in a research note titled "'Geography' Lesson." The analyst, however, disagrees. Earnings headlines are a "small fraction of meaning when it comes to forward fundamentals," contends Tusa. He says GE is missing guidance on core business EBIT that was set in March, "the latest of anyone in the sector," with the 10% shortfall the most of any of the large caps. The analyst keeps an Underweight rating on General Electric.
WEN Wendy's
$20.90

-0.01 (-0.05%)

11/06/19
SPHN
11/06/19
NO CHANGE
Target $24
SPHN
Overweight
Stephens 'encouraged' by sales trajectory in Wendy's core business
Stephens analyst Will Slabaugh said in a "first look" note reacting to Wendy's Q3 report that he is "encouraged" by the sales trajectory in its core business, especially ahead of the planned launch of breakfast in the first quarter of 2020. In addition to Q3 U.S. same-store sales growth of 4.4% that topped his and the consensus estimates prior to the company's pre-announcement at its at investor day, Slabaugh pointed to better adjusted EPS than was expected as a "surprise." Ahead of the company's earnings call, he has an Overweight rating and $24 price target on Wendy's shares.
10/14/19
RHCO
10/14/19
NO CHANGE
Target $26
RHCO
Buy
Wendy's price target raised to $26 from $24 at SunTrust
SunTrust analyst Jake Bartlett raised his price target on Wendy's to $26 and kept his Buy rating after its Investor Day presentation outlining its plans to launch breakfast items, grow its digital sales, and accelerate its international development. The analyst notes that while the breakfast entry and international expansion efforts are difficult to implement, the details offered by the management give him greater confidence in Wendy's growth prospects. Bartlett is lowering his FY19 EPS view by 2c to 55c to reflect the investment cost impact of the initiatives, but sees the company's long-term guidance as strong.
10/11/19
10/11/19
NO CHANGE

Stepehens boosts Wendy's target to $24, says outlook 'better than feared'
Stephens analyst Will Slabaugh maintained an Overweight rating on Wendy's and raised his price target on shares to $24 from $22 following the company's Investor Day presentation. The analyst believes that Wendy's breakfast rollout will be break-even, and called the stock attractive as he sees a mid-single-digit comp trajectory as breakfast is rolled out, which should offset the near-term free cash flow pressure. Additionally, he sees momentum in Wendy's core business and believes the company's guidance for FY20 is "better than feared," especially considering the investments currently being made in breakfast.
10/07/19
10/07/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Entegris (ENTG) downgraded to Hold from Buy at Deutsche Bank with analyst Sidney Ho saying the company's financial performance has done well in 2019 despite the semicap equipment market reeling from a sharp decline in memory spending. 2. Wendy's (WEN) downgraded to Market Perform from Outperform at Cowen with analyst Andrew Charles saying the company's decision to shift its focus from recovery to breakfast roll-out does not create a long-term competitive advantage as other companies have underperformed at Breakfast. 3. Carnival (CCL) downgraded to Hold from Buy at HSBC with analyst Ali Naqvi saying he reduced his target multiple for the shares to 10-times from 15-times to reflect Carnival's lower yield growth outlook, weak booking commentary and increasing capacity growth relative to peers. 4. HP Inc. (HPQ) downgraded to Hold from Buy at Argus with analyst Jim Kelleher citing its Analyst Day presentation, FY20 guidance, and announced job cuts, noting that the company's most profitable print & imaging business continues to struggle. 5. Ingersoll-Rand (IR) downgraded to Equal Weight from Overweight at Stephens with analyst Rob McCarthy saying he sees incremental concern for growth and sustainability of the HVAC cycle, and lowered his price target on the stock to $122, down from $124. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
BK BNY Mellon
$48.42

0.07 (0.14%)

10/02/19
WOLF
10/02/19
UPGRADE
Target $50
WOLF
Peer Perform
BNY Mellon upgraded to Peer Perform from Underperform at Wolfe Research
Wolfe Research analyst Steven Chubak upgraded BNY Mellon to Peer Perform from Underperform following a period of underperformance in the stock as "deep cuts" were being made to 2020 consensus forecasts. However, the bank's deposits are strongly correlated to Fed balance sheet assets and excess reserves and he expects net interest income headwinds to abate as the central bank is poised for balance sheet expansion, Chubak tells investors. He raised his price target on BNY Mellon shares to $50 from $45.
07/18/19
07/18/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Apple (AAPL) and Skyworks (SWKS) upgraded to Outperform from Market Perform at Raymond James with analyst Christopher Caso citing greater confidence in next year's 5G iPhone cycle. 2. PriceSmart (PSMT) upgraded to Outperform from Sector Perform at Scotiabank. 3. BNY Mellon (BK) upgraded to Market Perform from Underperform at Keefe Bruyette with analyst Brian Kleinhanzl saying after the company's Q2 results, he feels its negative catalysts are slowly reversing. 4. U.S. Bancorp (USB) upgraded to Neutral from Underperform at BofA/Merrill with analyst Erika Najarian saying she believes earnings headwinds have reached an inflection point and net interest margin is more defensible versus peers. 5. Power Integrations (POWI) upgraded to Buy from Hold at Stifel with analyst Tore Svanberg citing the company's near-term momentum from the USB-PD adoption cycle as well as its longer-term opportunity in the high-power industry and auto. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
07/18/19
KBWI
07/18/19
UPGRADE
Target $47
KBWI
Market Perform
BNY Mellon upgraded to Market Perform from Underperform at Keefe Bruyette
Keefe Bruyette analyst Brian Kleinhanzl upgraded BNY Mellon to Market Perform from Underperform and raised his price target for the shares to $47 from $46. Following the company's Q2 results, the analyst feels its negative catalysts are slowly reversing.
11/11/19
UBSW
11/11/19
UPGRADE
Target $55
UBSW
Buy
BNY Mellon upgraded to Buy from Neutral at UBS
UBS analyst Brennan Hawken upgraded BNY Mellon to Buy from Neutral with a price target of $55, up from $46. The analyst sees net interest income stabilization and improved cost control driving better than expected earnings growth in the near-term. BNY largely through its investment cycle, which should contain expense growth and lead to positive surprises, Hawken tells investors in a research note. In addition, the analyst sees less environmental pressure on the company's deposit growth now that the Federal Reserve is adding reserves to the banking system.
SYY Sysco
$81.51

0.27 (0.33%)

10/25/19
LOOP
10/25/19
NO CHANGE
Target $86
LOOP
Buy
Sysco price target raised to $86 from $78 at Loop Capital
Loop Capital analyst Andrew Wolf raised his price target on Sysco to $86 and kept his Buy rating ahead of its Q1 earnings on November 4th. The analyst sees continued "solid" pricing power in the food service distribution sector, along with a "decent" expense leverage driving the company's mid-to-high single-digit gains in operating profit.
08/12/19
WELS
08/12/19
NO CHANGE
Target $83
WELS
Outperform
Sysco Q4 report looks 'like a clearing event,' says Wells Fargo
Wells Fargo analyst Edward Kelly said Sysco's earnings report looks "like a clearing event" and he recommends buying the stock following a quarter that he said "was generally better than feared" and sets the stage for improved performance in fiscal 2020. The company "finally cut its aggressive three-year EBIT growth target" and although he would have liked to see guidance moved even lower, the revision should still remove a key overhang on the stock, said Kelly, who keeps an Outperform rating on Sysco shares.
11/05/19
BMOC
11/05/19
NO CHANGE
Target $88
BMOC
Outperform
Sysco price target raised to $88 from $80 at BMO Capital
BMO Capital analyst Kelly Bania raised her price target on Sysco to $88 and kept her Outperform rating after its slight Q1 earnings beat, saying she remains bullish on the "secular outlook for the independent restaurant segment" with expected acceleration in the company's local case growth. The analyst remains concerned about Sysco's weaker International outlook however, saying overseas trends remain "mixed."
10/04/19
WELS
10/04/19
NO CHANGE
Target $53
WELS
Outperform
Wells Fargo 'not overly concerned' about Amazon threat to Performance Food Group
Wells Fargo analyst Edward Kelly said he believes food service stocks, including Performance Food Group (PFGC) in particular, are weak due to a competing analyst's note highlighting that Amazon (AMZN) had a presence at a convenience store conference, sparking concern that the e-commerce giant may be looking to enter c-store distribution. Investors may also be concerned that this news "logically reintroduces the question" of whether Amazon is interested in traditional food service distribution to restaurants, Kelly added. However, he is "not overly concerned," stating that while safe to assume Amazon is looking into these businesses, and many others, that does not guarantee a meaningful presence or success. Also, C-store distribution requires tobacco to execute broadly and it is not clear if Amazon has interest in this product, Kelly contends. The analyst, who believes c-store exposure for Sysco (SYY) and US Foods (USFD) is "tiny," added that traditional food service is a tough business for a new entrant. While Amazon's "true ambition in any industry is difficult to assess and it makes sense to remain on alert," he would be a buyer of all three food distributor stocks mentioned amid the weakness, Kelly tells investors.

TODAY'S FREE FLY STORIES

RCKT

Rocket Pharmaceuticals

$24.22

1.22 (5.30%)

06:08
12/11/19
12/11
06:08
12/11/19
06:08
Syndicate
Rocket Pharmaceuticals 3.82M share Spot Secondary priced at $22.25 »

JPMorgan, Cowen and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CI

Cigna

$191.74

-4.15 (-2.12%)

06:08
12/11/19
12/11
06:08
12/11/19
06:08
Downgrade
Cigna rating change  »

Cigna downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Feb

SYBX

Synlogic

$2.75

0.28 (11.34%)

06:08
12/11/19
12/11
06:08
12/11/19
06:08
Hot Stocks
Synlogic obtains maximum dosage for phenylketonuria candidate »

Synlogic announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DIN

Dine Brands

$82.00

1.2 (1.49%)

06:08
12/11/19
12/11
06:08
12/11/19
06:08
Hot Stocks
Dine Brands' IHOP to launch new fast casual concept 'Flip'd' in spring 2020 »

IHOP Restaurants…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

EHC

Encompass Health

$71.78

0.17 (0.24%)

06:06
12/11/19
12/11
06:06
12/11/19
06:06
Downgrade
Encompass Health rating change  »

Encompass Health…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GEL

Genesis Energy

$20.15

1.13 (5.94%)

, MUR

Murphy Oil

$24.92

-0.06 (-0.24%)

06:06
12/11/19
12/11
06:06
12/11/19
06:06
Hot Stocks
Genesis Energy signs new deepwater GOM transportation agreements with Murphy Oil »

Genesis Energy (GEL)…

GEL

Genesis Energy

$20.15

1.13 (5.94%)

MUR

Murphy Oil

$24.92

-0.06 (-0.24%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

VIAC

ViacomCBS

$37.60

-1.05 (-2.72%)

, VIACA

ViacomCBS

$40.44

-1.34 (-3.21%)

06:05
12/11/19
12/11
06:05
12/11/19
06:05
Periodicals
ViacomCBS starting first round of layoffs, NY Post reports »

ViacomCBS is starting its…

VIAC

ViacomCBS

$37.60

-1.05 (-2.72%)

VIACA

ViacomCBS

$40.44

-1.34 (-3.21%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WCG

WellCare

$319.46

1.65 (0.52%)

06:04
12/11/19
12/11
06:04
12/11/19
06:04
Downgrade
WellCare rating change  »

WellCare downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WBA

Walgreens Boots Alliance

$58.40

-0.3 (-0.51%)

06:03
12/11/19
12/11
06:03
12/11/19
06:03
Downgrade
Walgreens Boots Alliance rating change  »

Walgreens downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Jan

PLAB

Photronics

$12.59

0.36 (2.94%)

06:03
12/11/19
12/11
06:03
12/11/19
06:03
Earnings
Photronics sees Q1 EPS 13c-18c, consensus 12c »

Sees Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

MDGL

Madrigal Pharmaceuticals

$118.45

1.16 (0.99%)

06:03
12/11/19
12/11
06:03
12/11/19
06:03
Syndicate
Madrigal Pharmaceuticals 1.2M share Spot Secondary priced at $107.85 »

Goldman Sachs acted as…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NEX

NexTier Oilfield

$5.66

0.07 (1.25%)

06:03
12/11/19
12/11
06:03
12/11/19
06:03
Hot Stocks
NexTier Oilfield announces up to $100M capital return program »

NexTier Oilfield…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HD

Home Depot

$215.84

-0.75 (-0.35%)

06:03
12/11/19
12/11
06:03
12/11/19
06:03
Earnings
Home Depot sees FY20 revenue up 3.5%-4% »

Sees FY20 SSS up 3.5%-4%.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 25

    Feb

ACHC

Acadia

$32.10

0.1 (0.31%)

06:03
12/11/19
12/11
06:03
12/11/19
06:03
Downgrade
Acadia rating change  »

Acadia downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BYND

Beyond Meat

$74.59

0.53 (0.72%)

06:02
12/11/19
12/11
06:02
12/11/19
06:02
Hot Stocks
Beyond Meat launches 'Beyond Beef' in Canada »

Canadians can now enjoy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PLAB

Photronics

$12.59

0.36 (2.94%)

06:02
12/11/19
12/11
06:02
12/11/19
06:02
Earnings
Photronics reports Q4 EPS 15c, consensus 15c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

FB

Facebook

$200.90

-0.42 (-0.21%)

06:02
12/11/19
12/11
06:02
12/11/19
06:02
Periodicals
Facebook fires contractor paid to reactivate banned ad accounts, BFN says »

Facebook has fired a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HD

Home Depot

$215.84

-0.75 (-0.35%)

06:02
12/11/19
12/11
06:02
12/11/19
06:02
Earnings
Home Depot backs FY19 EPS view of about $10.03, consensus $10.08 »

Backs FY19 revenue growth…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 25

    Feb

CRY

CryoLife

$24.21

-0.04 (-0.16%)

05:57
12/11/19
12/11
05:57
12/11/19
05:57
Upgrade
CryoLife rating change  »

CryoLife upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

THOR

Synthorx

$67.81

0.09 (0.13%)

05:56
12/11/19
12/11
05:56
12/11/19
05:56
Downgrade
Synthorx rating change  »

Synthorx downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ITRM

Iterum Therapeutics

$4.90

1.1 (28.95%)

05:55
12/11/19
12/11
05:55
12/11/19
05:55
Downgrade
Iterum Therapeutics rating change  »

Iterum Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SWMAY

Swedish Match

$0.00

(0.00%)

05:53
12/11/19
12/11
05:53
12/11/19
05:53
Initiation
Swedish Match initiated  »

Swedish Match initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LZRFY

Localiza

$0.00

(0.00%)

05:51
12/11/19
12/11
05:51
12/11/19
05:51
Upgrade
Localiza rating change  »

Localiza upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AKS

AK Steel

$3.41

0.08 (2.40%)

, CLF

Cleveland-Cliffs

$8.55

0.035 (0.41%)

05:49
12/11/19
12/11
05:49
12/11/19
05:49
Upgrade
AK Steel, Cleveland-Cliffs rating change  »

AK Steel upgraded to…

AKS

AK Steel

$3.41

0.08 (2.40%)

CLF

Cleveland-Cliffs

$8.55

0.035 (0.41%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SRDX

Surmodics

$40.95

0.02 (0.05%)

05:47
12/11/19
12/11
05:47
12/11/19
05:47
Downgrade
Surmodics rating change  »

Surmodics downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.